Condition
Bone Fragility
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
3 treatments under study, led by Hrpqct
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
Trial Status
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT01258036CompletedPrimary
Mother Daughter Bone Microarchitecture
NCT02572063Terminated
Omics4Aging: Stratification of Frailty Population
Showing all 2 trials
Research Network
Common Treatments
- Hrpqct1
- Bone Absorptiometry1
- Sampling1
Active Sponsors
- Institut National de la Santé Et de la Recherche Médicale, France1
- Société des Produits Nestlé (SPN)1
Top Investigators
Institut National de la Santé Et de la Recherche Médicale, France
Institut National de la Santé Et de la Recherche Médicale, France
University of Bologna
Related Conditions
- Intellectual Frailty Of Aging1
- Malnutrition1